Immune Biosolutions: Hatching new ideas

from left to right: Jean-François Larrivée, Co-founder and Director of Operations; Djordje Grbic, Post-doctoral fellow and Project leader; Martin Cloutier, Scientist

From left to right: Jean-François Larrivée, Co-founder and Director of Operations; Djordje Grbic, Post-doctoral fellow and Project leader; Martin Cloutier, Scientist

Summary

Entreprise: Immune Biosolutions

Region: Estrie

Program: The Quebec Economic Development Program (QEPD)

This financial assistance served to: business start-up and implementation of a commercialization plan.

 

The chicken or the egg

Sometimes a scientific breakthrough can cause quite a flap of excitement, especially when it involves chickens, ostriches, and eggs…

Immune Biosolutions produces and sells antibodies extracted from the egg yolks of chickens and ostriches. Unlike conventional processes that require the sacrifice or exsanguination of animals to generate the antibodies, the methods developed by Immune Biosolutions have the advantage of being greener and more humane because they only use the eggs.

An SME with flair

A University researcher using one of Immune Biosolutions’ Sunshine-in-a-box kits.

A University researcher using one of Immune Biosolutions’ Sunshine-in-a-box kits.

In 2012, Frédéric Leduc, Simon Gaudreau and Jean-François Larrivée founded Immune Biosolutions in a bid to produce high-quality antibodies. The three entrepreneurs—all Université de Sherbrooke graduates—wisely set up shop in the offices of the university’s Faculty of Medicine, thereby gaining privileged access to ultra-sophisticated laboratories and state-of-the-art equipment.

Success came quickly for the fledgling Sherbrooke-based firm: only a year later, in 2013, Immune Biosolutions won the Quebec Entrepreneurship Contest’s Youth Entrepreneurship Challenge and came in first—walking away with the BDC Grand Prize—in the Devtech 50 entrepreneurial competition. The company then went on to be named one of the five winners of the 2nd Devtech BIO competition, earning it the opportunity to take part in the prestigious BIO International Convention in Chicago, and was one of the 2013 recipients of the Spin Master Innovation Fund, a pan-Canadian innovation competition.

CED there from the start

Financial assistance from Canada Economic Development for Quebec regions (CED) served to support the firm’s start-up. More precisely, it allowed Immune Biosolutions to launch a commercialization strategy for Canada (Quebec, Ontario and the Maritimes), the United States (Boston), France, the United Kingdom, Sweden and Germany.

“Canada Economic Development helped kick-start commercialization of our products in the medical sector,” notes company president Frédéric Leduc.

A bright future for green solutions

Immune Biosolutions is proof positive that success and distinction can come from innovating and offering greener options to businesses. The hard work and dedication of its founders and employees are sure to lead this company to even greater heights and into more markets all over the world.

Date modified: